BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kaur J, Cao X, Abutaleb NS, Elkashif A, Graboski AL, Krabill AD, AbdelKhalek AH, An W, Bhardwaj A, Seleem MN, Flaherty DP. Optimization of Acetazolamide-Based Scaffold as Potent Inhibitors of Vancomycin-Resistant Enterococcus. J Med Chem 2020;63:9540-62. [PMID: 32787141 DOI: 10.1021/acs.jmedchem.0c00734] [Cited by in Crossref: 14] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 De Luca V, Carginale V, Supuran CT, Capasso C. The gram-negative bacterium Escherichia coli as a model for testing the effect of carbonic anhydrase inhibition on bacterial growth. J Enzyme Inhib Med Chem 2022;37:2092-8. [PMID: 35899716 DOI: 10.1080/14756366.2022.2101644] [Reference Citation Analysis]
2 An W, Holly KJ, Nocentini A, Imhoff RD, Hewitt CS, Abutaleb NS, Cao X, Seleem MN, Supuran CT, Flaherty DP. Structure-activity relationship studies for inhibitors for vancomycin-resistant Enterococcus and human carbonic anhydrases. J Enzyme Inhib Med Chem 2022;37:1838-44. [PMID: 35758212 DOI: 10.1080/14756366.2022.2092729] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Mancuso F, Angeli A, De Luca V, Bucolo F, De Luca L, Capasso C, Supuran CT, Gitto R. Synthesis and biological evaluation of sulfonamide-based compounds as inhibitors of carbonic anhydrase from Vibrio cholerae. Arch Pharm (Weinheim) 2022;:e2200070. [PMID: 35739618 DOI: 10.1002/ardp.202200070] [Reference Citation Analysis]
4 Urbański LJ, Bua S, Angeli A, Emameh RZ, Barker HR, Kuuslahti M, Hytönen VP, Parkkila S, Supuran CT. The production and biochemical characterization of α-carbonic anhydrase from Lactobacillus rhamnosus GG. Appl Microbiol Biotechnol 2022. [PMID: 35612631 DOI: 10.1007/s00253-022-11990-3] [Reference Citation Analysis]
5 D'Agostino I, Mathew GE, Angelini P, Venanzoni R, Angeles Flores G, Angeli A, Carradori S, Marinacci B, Menghini L, Abdelgawad MA, Ghoneim MM, Mathew B, Supuran CT. Biological investigation of N-methyl thiosemicarbazones as antimicrobial agents and bacterial carbonic anhydrases inhibitors. J Enzyme Inhib Med Chem 2022;37:986-93. [PMID: 35322729 DOI: 10.1080/14756366.2022.2055009] [Reference Citation Analysis]
6 Scott JA, Soto-Velasquez M, Hayes MP, LaVigne JE, Miller HR, Kaur J, Ejendal KFK, Watts VJ, Flaherty DP. Optimization of a Pyrimidinone Series for Selective Inhibition of Ca2+/Calmodulin-Stimulated Adenylyl Cyclase 1 Activity for the Treatment of Chronic Pain. J Med Chem 2022. [PMID: 35271288 DOI: 10.1021/acs.jmedchem.1c01759] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Giovannuzzi S, Hewitt CS, Nocentini A, Capasso C, Flaherty DP, Supuran CT. Coumarins effectively inhibit bacterial α-carbonic anhydrases. J Enzyme Inhib Med Chem 2022;37:333-8. [PMID: 34979838 DOI: 10.1080/14756366.2021.2012174] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Sun H, Huang SY, Jeyakkumar P, Cai GX, Fang B, Zhou CH. Natural Berberine-derived Azolyl Ethanols as New Structural Antibacterial Agents against Drug-Resistant Escherichia coli. J Med Chem 2021. [PMID: 34964345 DOI: 10.1021/acs.jmedchem.1c01592] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
9 Havránková E, Garaj V, Mascaretti Š, Angeli A, Soldánová Z, Kemka M, Motyčka J, Brázdová M, Csöllei J, Jampílek J, Supuran CT. Novel 1,3,5-Triazinyl Aminobenzenesulfonamides Incorporating Aminoalcohol, Aminochalcone and Aminostilbene Structural Motifs as Potent Anti-VRE Agents, and Carbonic Anhydrases I, II, VII, IX, and XII Inhibitors. Int J Mol Sci 2021;23:231. [PMID: 35008657 DOI: 10.3390/ijms23010231] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Giovannuzzi S, Abutaleb NS, Hewitt CS, Carta F, Nocentini A, Seleem MN, Flaherty DP, Supuran CT. Dithiocarbamates effectively inhibit the α-carbonic anhydrase from Neisseria gonorrhoeae. J Enzyme Inhib Med Chem 2022;37:1-8. [PMID: 34894954 DOI: 10.1080/14756366.2021.1988945] [Reference Citation Analysis]
11 Abutaleb NS, Elhassanny AEM, Nocentini A, Hewitt CS, Elkashif A, Cooper BR, Supuran CT, Seleem MN, Flaherty DP. Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of Neisseria gonorrhoeae. J Enzyme Inhib Med Chem 2022;37:51-61. [PMID: 34894972 DOI: 10.1080/14756366.2021.1991336] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
12 Fan SH, Liberini E, Götz F. Staphylococcus aureus Genomes Harbor Only MpsAB-Like Bicarbonate Transporter but Not Carbonic Anhydrase as Dissolved Inorganic Carbon Supply System. Microbiol Spectr 2021;:e0097021. [PMID: 34730408 DOI: 10.1128/Spectrum.00970-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Grande R, Carradori S, Puca V, Vitale I, Angeli A, Nocentini A, Bonardi A, Gratteri P, Lanuti P, Bologna G, Simeone P, Capasso C, De Luca V, Supuran CT. Selective Inhibition of Helicobacter pylori Carbonic Anhydrases by Carvacrol and Thymol Could Impair Biofilm Production and the Release of Outer Membrane Vesicles. Int J Mol Sci 2021;22:11583. [PMID: 34769015 DOI: 10.3390/ijms222111583] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
14 Urbański LJ, Angeli A, Mykuliak VV, Azizi L, Kuuslahti M, Hytönen VP, Supuran CT, Parkkila S. Biochemical and structural characterization of beta-carbonic anhydrase from the parasite Trichomonas vaginalis. J Mol Med (Berl) 2021. [PMID: 34652457 DOI: 10.1007/s00109-021-02148-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Flaherty DP, Seleem MN, Supuran CT. Bacterial carbonic anhydrases: underexploited antibacterial therapeutic targets. Future Med Chem 2021. [PMID: 34382415 DOI: 10.4155/fmc-2021-0207] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
16 De Luca V, Petreni A, Carginale V, Scaloni A, Supuran CT, Capasso C. Effect of amino acids and amines on the activity of the recombinant ι-carbonic anhydrase from the Gram-negative bacterium Burkholderia territorii. J Enzyme Inhib Med Chem 2021;36:1000-6. [PMID: 33980103 DOI: 10.1080/14756366.2021.1919891] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Supuran CT. Multitargeting approaches involving carbonic anhydrase inhibitors: hybrid drugs against a variety of disorders. J Enzyme Inhib Med Chem 2021;36:1702-14. [PMID: 34325588 DOI: 10.1080/14756366.2021.1945049] [Reference Citation Analysis]
18 Hewitt CS, Abutaleb NS, Elhassanny AEM, Nocentini A, Cao X, Amos DP, Youse MS, Holly KJ, Marapaka AK, An W, Kaur J, Krabill AD, Elkashif A, Elgammal Y, Graboski AL, Supuran CT, Seleem MN, Flaherty DP. Structure-Activity Relationship Studies of Acetazolamide-Based Carbonic Anhydrase Inhibitors with Activity against Neisseria gonorrhoeae. ACS Infect Dis 2021;7:1969-84. [PMID: 33765392 DOI: 10.1021/acsinfecdis.1c00055] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 11.0] [Reference Citation Analysis]
19 Provensi G, Nocentini A, Passani MB, Blandina P, Supuran CT. Activation of carbonic anhydrase isoforms involved in modulation of emotional memory and cognitive disorders with histamine agonists, antagonists and derivatives. J Enzyme Inhib Med Chem 2021;36:719-26. [PMID: 33648390 DOI: 10.1080/14756366.2021.1891051] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Sun H, Ansari MF, Fang B, Zhou CH. Natural Berberine-Hybridized Benzimidazoles as Novel Unique Bactericides against Staphylococcus aureus. J Agric Food Chem 2021;69:7831-40. [PMID: 34228443 DOI: 10.1021/acs.jafc.1c02545] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
21 Bonardi A, Nocentini A, Osman SM, Alasmary FA, Almutairi TM, Abdullah DS, Gratteri P, Supuran CT. Inhibition of α-, β- and γ-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae with aromatic sulphonamides and clinically licenced drugs - a joint docking/molecular dynamics study. J Enzyme Inhib Med Chem 2021;36:469-79. [PMID: 33472446 DOI: 10.1080/14756366.2020.1862102] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
22 Urbanski LJ, Vullo D, Parkkila S, Supuran CT. An anion and small molecule inhibition study of the β-carbonic anhydrase from Staphylococcus aureus. J Enzyme Inhib Med Chem 2021;36:1088-92. [PMID: 34056990 DOI: 10.1080/14756366.2021.1931863] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
23 Nocentini A, Hewitt CS, Mastrolorenzo MD, Flaherty DP, Supuran CT. Anion inhibition studies of the α-carbonic anhydrases from Neisseria gonorrhoeae. J Enzyme Inhib Med Chem 2021;36:1061-6. [PMID: 34030562 DOI: 10.1080/14756366.2021.1929202] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
24 Supuran CT. Emerging role of carbonic anhydrase inhibitors. Clin Sci (Lond) 2021;135:1233-49. [PMID: 34013961 DOI: 10.1042/CS20210040] [Cited by in Crossref: 8] [Cited by in F6Publishing: 44] [Article Influence: 8.0] [Reference Citation Analysis]
25 Supuran CT, Capasso C. A Highlight on the Inhibition of Fungal Carbonic Anhydrases as Drug Targets for the Antifungal Armamentarium. Int J Mol Sci 2021;22:4324. [PMID: 33919261 DOI: 10.3390/ijms22094324] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
26 Chojnacki M, Cao X, Flaherty DP, Dunman PM. Optimization of 2-Acylaminocycloalkylthiophene Derivatives for Activity against Staphylococcus aureus RnpA. Antibiotics (Basel) 2021;10:369. [PMID: 33807357 DOI: 10.3390/antibiotics10040369] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Abutaleb NS, Elhassanny AEM, Flaherty DP, Seleem MN. In vitro and in vivo activities of the carbonic anhydrase inhibitor, dorzolamide, against vancomycin-resistant enterococci. PeerJ 2021;9:e11059. [PMID: 33850651 DOI: 10.7717/peerj.11059] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
28 Campestre C, De Luca V, Carradori S, Grande R, Carginale V, Scaloni A, Supuran CT, Capasso C. Carbonic Anhydrases: New Perspectives on Protein Functional Role and Inhibition in Helicobacter pylori. Front Microbiol 2021;12:629163. [PMID: 33815311 DOI: 10.3389/fmicb.2021.629163] [Cited by in Crossref: 2] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
29 Abutaleb NS, Elkashif A, Flaherty DP, Seleem MN. In Vivo Antibacterial Activity of Acetazolamide. Antimicrob Agents Chemother 2021;65:e01715-20. [PMID: 33495225 DOI: 10.1128/AAC.01715-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
30 De Luca V, Petreni A, Nocentini A, Scaloni A, Supuran CT, Capasso C. Effect of Sulfonamides and Their Structurally Related Derivatives on the Activity of ι-Carbonic Anhydrase from Burkholderia territorii. Int J Mol Sci 2021;22:E571. [PMID: 33430028 DOI: 10.3390/ijms22020571] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
31 Petreni A, De Luca V, Scaloni A, Nocentini A, Capasso C, Supuran CT. Anion inhibition studies of the Zn(II)-bound ι-carbonic anhydrase from the Gram-negative bacterium Burkholderia territorii. J Enzyme Inhib Med Chem 2021;36:372-6. [PMID: 33390061 DOI: 10.1080/14756366.2020.1867122] [Cited by in Crossref: 3] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
32 Urbański LJ, Angeli A, Hytönen VP, Di Fiore A, De Simone G, Parkkila S, Supuran CT. Inhibition of the β-carbonic anhydrase from the protozoan pathogen Trichomonas vaginalis with sulphonamides. J Enzyme Inhib Med Chem 2021;36:329-34. [PMID: 33356653 DOI: 10.1080/14756366.2020.1863958] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Supuran CT. Experimental Carbonic Anhydrase Inhibitors for the Treatment of Hypoxic Tumors. J Exp Pharmacol 2020;12:603-17. [PMID: 33364855 DOI: 10.2147/JEP.S265620] [Cited by in Crossref: 19] [Cited by in F6Publishing: 45] [Article Influence: 9.5] [Reference Citation Analysis]
34 Supuran CT, Capasso C. Antibacterial carbonic anhydrase inhibitors: an update on the recent literature. Expert Opin Ther Pat 2020;30:963-82. [PMID: 32806966 DOI: 10.1080/13543776.2020.1811853] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]